29.11.2016 14:50:00

Potential Booming of the "Green" Rush

NEW YORK, November 29, 2016 /PRNewswire/ --

It's no secret that after the recent historical legalizations, the fastest-growing industry in the United States will soon be the cannabis market. ArcView Market Research released its fourth edition of "The State of Legal Marijuana Markets" report, which includes forecast of the legal cannabis market projecting it will generate $21.8 billion annual sales by 2020. Green Cures & Botanical Distribution Inc. (OTC: GRCU), Cannabis Science Inc. (OTC: CBIS), Cannabics Pharmaceuticals Inc. (OTC: CNBX), American Cannabis Company Inc. (OTC: AMMJ), Marijuana Company of America Inc. (OTC: MCOA).

The research group also made comparison of the legal marijuana market which could surpass national Football League, which saw roughly $12 billion of revenue last year but is pointing to reach $25 billion by 2027. Additionally, 60 percent of Americans want to legalize cannabis with an increase of 31 percent compared to 2000. The largest economy is California and now tripled its national cannabis industry.

Green Cures & Botanical Distribution Inc. (OTC: GRCU) states that it is revenue-generating company that wholesales and retails hemp-infused nutritional, botanical, sports, and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc., operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production and distribution, Green Cures & Botanical Distribution Inc., is continuously creating and introducing products that promote a healthy life style.

Green Cures & Botanical Distribution Inc. announced after the close yesterday that, Purple Haze Properties also previewed the new Jimi Hendrix inspired beverage line and Digital Underground sodas being launched with Green Cures and Botanical Distribution Inc. "I can't wait for these great celebrity beverages to come out, I have sampled some of the flavors and they are out of this world", states Leon Hendrix, Chief Legacy Officer of Purple Haze Properties. "We are in the final stages of getting the products out and will be announcing what supermarkets will be participating in the launch. I look forward to the amazing CBD hemp-infused products hitting the supermarkets this holiday season."

In addition to this exciting debut in Las Vegas, Michael Lajtay (Pronounced "Lay-tay") Chief Operating Officer of GRCU, reports that he taped the first of several interviews on the well-known TVC Latino Spanish Cable Network regarding the new GRCU produced Roberto Duran Champion Energy Shots. Mr. Lajtay states, "On November 23rd I was interviewed by Carlos Santana, news anchor of TVC Latino in Los Angeles. TVC Latino is the US feed for the number 1 cable system in Mexico, the network reaches every Spanish speaking and Hispanic country in the world which comprise many of Roberto Duran's loyal fans." Mr. Lajtay also states, "The Roberto Duran Champion Energy Shots are well timed to capitalize on the feature film starring Roberto De Niro entitled, "Hands of Stone", about the career of Roberto Duran as well as his autobiography entitled "I am Duran".

Cannabis Science Inc. (OTC: CBIS) has plans to initiate a long anticipated medication study for Pulmonary Patients suffering from varying failing lung functions stemming from Cancers to Bronchitis and all in between respiratory ailments. "We expect it will begin as soon as the First Lab and Extraction site is completed and we think this will take place in this month of November," stated CEO and Co-founder Raymond C. Dabney. The company's goals along with medications are the delivery systems mandatory and believed to be helpful to the patient. While treatments in pill form or inhaled medications serve well for maintenance purposes and long term regimens, often times much of a medication's healing benefit is absent through the delivery method. While this does not diminish the need for these maintenance type and quick relief medications, a targeted method for more serious times of the targeted disease is not only required but a necessity.

Cannabics Pharmaceuticals Inc. (OTC: CNBX) has commenced the study in Israel for cancer patients utilizing Cannabics' SR Capsules. This is one of the world's only clinical study explicitly investigating the effects of cannabis utilizing a medically standardized edible delivery system. The company describes itself as a licensed research and development based in Israel dedicated to the development of palliative and personalized Anti-Cancer treatments harnessing the versatile therapeutic values of cannabinoids to create tailored therapies for cancer patients.

American Cannabis Company Inc. (OTCQB: AMMJ) has signed a client in the state of Pennsylvania for the state's medical marijuana program for the near future.  The company expects to leverage this contract to lock profits through long-term consulting arrangements, sales of ancillary products and amenities to aid cultivation operations. President and CEO of American Cannabis Company, Corey Hollister commented: "As the sixth most populated state in the country, Pennsylvania is a major market in the growing medical cannabis framework. Our new client operates with the business acumen and a track record of success from within other sectors, and this experience will be key for them in the effort to realize their goal of operating within Pennsylvania's new medical marijuana program."

Marijuana Company of America Inc. (OTC: MCOA) launched its unique inaugural product hempSMART Brain. This product has Cannabidiol as its core element combined with high elements, branded ingredients to compliment the Cannabidiol to upkeep for brain health. HempSMART BRAIN is articulated to meet the cumulative request for products with therapeutic benefits that supports brain function. This state-of-the-art product has a synergistic blend of verified natural brain support ingredients that is combined with water soluble Cannabidiol to deliver top bio availability for brain support and safeguard.

For "The Latest Buzz in Financial News", SIGN UP & Visit: http://www.FinancialBuzz.com

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com  

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and pr marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. Financialbuzz.com has been compensated a total of fifteen thousand dollars for financial news dissemination and pr services by a non-affiliated third party for green cures & botanical distribution inc. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information:

Media Contact: info@financialbuzz.com , +1-877-601-1879

Url: FinancialBuzz.com

SOURCE FinancialBuzz.com

Nachrichten zu Cannabics Pharmaceuticalsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Cannabics Pharmaceuticalsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

American Cannabis Company Inc 0,00 0,00% American Cannabis Company Inc